Pliant Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ACLX
Arcellx, Inc. |
$64.02 | $2.72 B | -49.3 | 130 | $110.32 M |
ARVN
Arvinas, Inc. |
$18.11 | $1.83 B | -4.41 | 445 | $78.50 M |
BCEL
Atreca, Inc. |
$0.09 | $3.66 M | -0.04 | 90 | $770,000 |
BDTX
Black Diamond Therapeutics, Inc. |
$2.48 | $291.95 M | -3.13 | 54 | $0 |
CYTK
Cytokinetics, Incorporated |
$49.62 | $6.05 B | -9.78 | 423 | $7.53 M |
DYN
Dyne Therapeutics, Inc. |
$13.98 | $3.03 B | -7.77 | 173 | $0 |
ETNB
89bio, Inc. |
$7.10 | $796.91 M | -4.05 | 70 | $0 |
INZY
Inozyme Pharma, Inc. |
$1.41 | $286.39 M | -3.43 | 59 | $0 |
MDGL
Madrigal Pharmaceuticals, Inc. |
$333.50 | $5.21 B | -10.55 | 376 | $0 |
PASG
Passage Bio, Inc. |
$0.60 | $73.04 M | -0.77 | 58 | $0 |
RLAY
Relay Therapeutics, Inc. |
$4.90 | $1.05 B | -3 | 294 | $25.55 M |
RVMD
Revolution Medicines, Inc. |
$41.07 | $6.66 B | -10.51 | 490 | $11.58 M |
SNDX
Syndax Pharmaceuticals, Inc. |
$14.52 | $1.66 B | -6.02 | 184 | $0 |
STOK
Stoke Therapeutics, Inc. |
$10.69 | $774.50 M | -6.14 | 110 | $8.78 M |
TCRR
TCR2 Therapeutics Inc. |
$1.48 | $58.11 M | -0.35 | 58 | $0 |
VRDN
Viridian Therapeutics, Inc. |
$18.58 | $776.72 M | -2.71 | 94 | $314,000 |